October 06, 2025

Can Nicotinamide Reduce the Risk of Skin Cancer Development?

A retrospective study aimed to determine the clinical efficacy of nicotinamide supplementation for skin cancer prevention in the general population and among solid organ transplant recipients.

The ASCO Post

October 06, 2025

Dupilumab Shows High Treatment Persistence in AD

Biologics target type 2 inflammation in atopic dermatitis, improving skin barrier and symptoms.

Conexiant

October 02, 2025

Nicotinamide Use Reduces SCC in Veterans With Prior Skin Cancer

Veterans were prescribed nicotinamide twice daily following prior skin cancer.

Conexiant

October 02, 2025

Medical Oddities: Early Embryos Made From Skin Cells?

Science serves up embryos, lattes, flu flavors, and a crash course in kids’ safety.

Conexiant

October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

September 29, 2025

Sunburns Linked to Squamous Cell Carcinoma Risk

Childhood severe sunburns carry 3-fold higher cancer risk than adult exposure

Conexiant

September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 26, 2025

Cutaneous Squamous Cell Carcinoma: AI Model Rivals Dermatologists in Differentiation Assessment

Performance of a convolutional neural network in determining differentiation levels of cutaneous squamous cell carcinomas was on par with that of experienced dermatologists, according to the results o...

The ASCO Post

September 25, 2025

Mediterranean Diet Cut Psoriasis Severity Over 16 Weeks

Dietitian-guided Mediterranean diet increases adherence and improves patient-reported psoriasis measures.

Conexiant